Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging

NCT: NCT04086082 · RECRUITING

NCT IDNCT04086082
StatusRECRUITING
Start Date2023-05-24
Completion2028-12

Brief Summary

This trial will investigate the feasibility of the Markerless Tumour Tracking technology.

Frequently Asked Questions

What is Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging?

Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging is a clinical trial registered under NCT04086082. Current status: RECRUITING.

What is the status of NCT04086082?

The current status of NCT04086082 (Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging) is: RECRUITING.

When did Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging start?

Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging started on 2023-05-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑